Its main goal is to influence important cellular processes related to aging, cellular senescence, and programmed cell death, also known as apoptosis
"Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor"
She notes that weight loss is not always visible only in the areas preferred by patients but can affect other parts of the body
This significant weight reduction was accompanied by improvements in various health markers, including waist circumference, blood pressure, and cholesterol levels
Before prescribing, clinicians should confirm appropriate indicationseither inadequately controlled type 2 diabetes or obesity with BMI 30 kg/m (or 27 kg/m with weight-related comorbidities such as hypertension or dyslipidemia)
Patients starting GLP-1 therapy Patients adjusting doses Patients wanting to reduce side effects or progress Patients who love data or structure The Meds Supported medications Shotsy supports commonly prescribed GLP-1 treatments, including semaglutide and tirzepatide, in both injectable and oral forms, as well as brand-name and compounded options